Cigarette smoking is a very dangerous habit which not only affects your emotional health, but also physical health. Many studies have proven that cigarette smoking has damaging effects on the cardiovascular system, lung health, respiratory health, as well as the immune and nervous systems. So, as a smoker you should know that it is important to quit smoking as soon as possible.
Citing a growing body of research, a scientist has concluded that people who use psychedelics as part of their treatment for nicotine addiction have a 93 percent greater success rate than people who do not take psychedelics. This is the first time, that this type of research has been conducted on people who use psychedelics for this purpose. The study examined the use of magic mushrooms, LSD, and psilocybin, which are all substances that are classified as Schedule 1 Controlled Substances.
In order to quit smoking cigarettes, a person must first have a desire to stop. The desire to stop smoking cigarettes is what drives a person to seek assistance. The assistance sought is in the form of medications to help the person to stop smoking.
Psychedelics may be exactly what’s needed to break addictive habits like smoking.
According to the US Centers for Disease Control and Prevention and the US Department of Health and Human Services, tobacco smoking is the top avoidable cause of death in the US. However, scientists believe that psychedelics have a unique capacity to activate brain pathways that lead to addiction, particularly nicotine addiction.
On August 18, Mydecine Innovations Group established a five-year research partnership with Johns Hopkins University School of Medicine to investigate the effectiveness of psychedelic formulations for smoking cessation.
While Mydecine Innovations Group is keeping the kinds of psychedelics used in the study a secret, researchers have previously looked at psilocybin for addiction therapy and ketamine for addiction treatment, to name a few.
In a news statement, Mydecine CEO Josh Bartch said, “We are thrilled to build on the present work we are doing with Dr. Matt Johnson and his team at JHU in relation to smoking cessation to encompass many additional initiatives over the next five years.” “The JHU researchers have shown their extraordinary breadth of expertise in the field.”
Dr. Matthew W. Johnson, Ph. D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University, will lead the research. While medical research into psychedelics is still in its infancy, the Johns Hopkins Behavioral Pharmacology Research Unit has a long history of performing clinical research on psychedelics for therapeutic reasons.
Rob Roscow, Chief Scientific Officer and Co-Founder of Mydecine, stated, “The long-term potential of this research collaboration is fascinating for us here at Mydecine.” “It shows our dedication to advance psychedelic medicine by examining a wide range of compounds and medications for various indications.”
Despite the recent emphasis on opioid addiction, the researchers stressed the importance of remembering the fatalities caused by cigarettes.
“Despite the current focus on opiate and other illegal drug addiction, we often overlook the enormous impact that nicotine addiction has on our societies,” said Dr. Rakesh Jetly, Chief Medical Officer, Mydecine. “According to the Centers for Illness Control and Prevention (CDC), cigarette smoking is the greatest cause of avoidable disease and death in the United States, killing over 480,000 people each year. Despite all of the public education and grave warnings, cigarette smoking remains one of the most hardest addictions to cure, contributing to more fatalities than all other drugs combined, necessitating studies such as this.”
Tobacco smoking vs. Cannabis smoking
Despite frequent freak-outs after eating edibles, the National Institute on Drug Abuse finds that cannabis does not usually lead to overdoses, despite the fact that tobacco kills almost half a million Americans each year.
According to the group, “there have been no instances of adolescents or young adults dying from a marijuana overdose alone.” “However, there have been instances of people seeking care in emergency departments after ingesting high THC levels in smoked marijuana or marijuana edibles and experiencing unpleasant side effects.”
There is a significant difference between cannabis smoke and tobacco smoke in terms of carcinogenicity. However, there are many reasons to give up smoking.
The American Cancer Society presents a grim picture of how big of a difference it may make if you stop smoking cigarettes. Within minutes or hours of stopping, your body changes.
Your heart rate and blood pressure will decrease 20 minutes after you stop smoking. The carbon monoxide level in your blood returns to normal a few days after you stop smoking. Your circulation improves and your lung function improves two to three months after you stop smoking. Coughing and shortness of breath diminish one to twelve months after stopping.
The American Cancer Society says that “tiny hair-like structures (called cilia) that transport mucus out of the lungs begin to recover normal function, improving their capacity to manage mucus, clean the lungs, and decrease the risk of infection.” Your risk of heart attack decreases significantly one to two years after you stop smoking.
What occurs in the long run is as follows:
Your risk of malignancies of the mouth, throat, and voice box is reduced in half five to ten years after stopping. Your chances of having a stroke diminish. Your risk of lung cancer is approximately half that of someone who continues to smoke ten years after stopping (after 10-15 years). Cancers of the bladder, esophagus, and kidney are also reduced. After stopping smoking for fifteen years, your risk of coronary heart disease is comparable to that of a nonsmoker.
There has been a lot of debate over whether or not psychedelics have any benefits to smoking cessation. For example, a 2011 study found that psilocybin helped adult smokers to quit, and a 2013 study found that LSD helped smokers to reduce their smoking. However, these studies have had little to no replication, and the results in both cases have been mixed. There have been no studies looking at the smoking cessation benefits of Psychedlics in the context of cigarette smoking cessation.. Read more about mushroom drug cigarettes and let us know what you think.
This article broadly covered the following related topics:
- quit smoking magic
- quit smoking baltimore
- magic way to quit smoking
- johns hopkins smoking cessation program
- clinical trials smoking cessation